We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-3.55%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$16B
AUM Growth
-$1.4B
Cap. Flow
-$442M
Cap. Flow %
-2.77%
Top 10 Hldgs %
29.19%
Holding
720
New
51
Increased
199
Reduced
358
Closed
49

Top Sells

Rank Stock Value
1
ALTR
Altair Engineering Inc
ALTR
+$67M
2
UNH icon
UnitedHealth
UNH
+$44.7M
3
APH icon
Amphenol
APH
+$43.9M
4
BDX icon
Becton Dickinson
BDX
+$36.4M
5
LLY icon
Eli Lilly
LLY
+$36.1M

Sector Composition

Rank Sector Weight
1 Technology 31.51%
2 Healthcare 25.4%
3 Financials 11.6%
4 Consumer Discretionary 7.99%
5 Industrials 7.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TSLA icon
26
Tesla
TSLA
$1.22T
$134M 0.84%
515,989
+44,998
+10% +$15M
EMR icon
27
Emerson Electric
EMR
$83.3B
$115M 0.72%
1,046,319
-84,322
-7% -$10.2M
NOW icon
28
ServiceNow
NOW
$106B
$97.9M 0.61%
614,720
-63,960
-9% -$12.3M
VRTX icon
29
Vertex Pharmaceuticals
VRTX
$123B
$96.1M 0.6%
198,287
-60,335
-23% -$28.1M
MU icon
30
Micron Technology
MU
$993B
$96.1M 0.6%
1,106,241
+56,088
+5% +$5.39M
PGR icon
31
Progressive
PGR
$125B
$94.2M 0.59%
333,018
-32,216
-9% -$8.43M
ADSK icon
32
Autodesk
ADSK
$46.8B
$87.6M 0.55%
334,659
+24,520
+8% +$6.97M
AXP icon
33
American Express
AXP
$227B
$86.4M 0.54%
321,242
-19,723
-6% -$5.83M
DHR icon
34
Danaher
DHR
$135B
$85M 0.53%
399,324
+50,438
+14% +$11M
ABT icon
35
Abbott
ABT
$183B
$84.8M 0.53%
639,070
+45,315
+8% +$5.77M
ABBV icon
36
AbbVie
ABBV
$461B
$84.1M 0.53%
401,498
-13,340
-3% -$2.59M
ZTS icon
37
Zoetis
ZTS
$32.3B
$82.1M 0.51%
498,761
+395
+0.1% +$65.7K
MCK icon
38
McKesson
MCK
$100B
$81.7M 0.51%
121,403
+14,514
+14% +$8.97M
ECL icon
39
Ecolab
ECL
$76.2B
$78.6M 0.49%
309,964
-31,204
-9% -$7.87M
WAB icon
40
Wabtec
WAB
$50.4B
$78.5M 0.49%
432,976
-33,040
-7% -$6.34M
TJX icon
41
TJX Companies
TJX
$172B
$78.3M 0.49%
642,961
-3,270
-0.5% -$397K
ONC
42
BeOne Medicines Ltd
ONC
$33.8B
$77.8M 0.49%
+285,893
New +$66.8M
VEEV icon
43
Veeva Systems
VEEV
$31.5B
$77M 0.48%
332,222
+30,252
+10% +$6.91M
MELI icon
44
Mercado Libre
MELI
$93.6B
$73.3M 0.46%
37,571
+7,174
+24% +$14.2M
CDNS icon
45
Cadence Design Systems
CDNS
$93.3B
$72M 0.45%
282,980
-14,408
-5% -$4.01M
ON icon
46
ON Semiconductor
ON
$33.9B
$71.4M 0.45%
1,754,594
+700,033
+66% +$35.2M
BKNG icon
47
Booking.com
BKNG
$143B
$68.5M 0.43%
371,925
+8,725
+2% +$1.67M
SYK icon
48
Stryker
SYK
$129B
$68.2M 0.43%
183,267
+1,985
+1% +$755K
ALNY icon
49
Alnylam Pharmaceuticals
ALNY
$37.5B
$67.5M 0.42%
249,919
-32,488
-12% -$8.35M
BMY icon
50
Bristol-Myers Squibb
BMY
$129B
$66.8M 0.42%
1,095,365
-411,091
-27% -$24M

Similar funds

Candriam SCA's Q1 2025 Portfolio in Review

As of Q1 2025, Candriam SCA held 720 positions worth $16B, down 8.1% from $17.4B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Candriam SCA's Q1 2025 filing shows 51 new, 199 increased, 358 reduced and 49 closed positions. Its largest new stake was BeOne Medicines Ltd: 285,893 shares worth $77.8M. The largest sale was Altair Engineering Inc, an estimated $67M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 34% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q1 2025 buy was BeOne Medicines Ltd: 285,893 shares worth $77.8M.
  • Candriam SCA added most to Meta Platforms (Facebook) in Q1 2025, an estimated $121M increase.
  • Candriam SCA's biggest Q1 2025 reduction was UnitedHealth, cutting an estimated $44.7M.
  • Candriam SCA fully exited Altair Engineering Inc in Q1 2025, selling an estimated $67M.
  • Candriam SCA's ten largest holdings make up 29% of its $16B portfolio in Q1 2025.
  • Candriam SCA opened 51 new positions and closed 49 in Q1 2025.
  • Candriam SCA's portfolio value fell 8.1% quarter-over-quarter to $16B.

Based on Candriam SCA's 13F filing for Q1 2025, filed 14 May 2025.